Indegene is a global enterprise healthtech solutions provider, delivering innovative services to life sciences companies, payers, and providers. By integrating deep industry expertise with advanced analytics and technology, Indegene assists healthcare organizations in enhancing productivity and improving health outcomes. Their unique blend of healthcare domain knowledge and technological prowess has positioned them as a leader in the healthtech industry.
PARAMETERS | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2014 | 2013 | 2012 | 2011 | 2010 |
---|---|---|---|---|---|---|---|---|---|---|---|
Revenue (INR Cr) | 2759 16.7% | 2364 39.9% | 1691 63.6% | 1034 59.8% | 647 15.6% | 560 496.7% | 94 10.0% | 85 38.8% | 61 48.9% | 41 26.2% | 33 - |
Net Operating Income (INR Cr) | 2590 12.29% | 2306 38.54% | 1665 72.27% | 966 50.29% | 643 16.20% | 553 0.00% | 89 7.33% | 83 37.77% | 60 50.44% | 40 25.62% | 32 0.00% |
Profit (INR Cr) | 337 26.5% | 266 61.5% | 165 10.3% | 149 - | -6 - | 14 83.7% | 8 16.2% | 7 8.2% | 6 38.6% | 4 17.3% | 4 - |
Assets (INR Cr) | 2026 16.6% | 1738 85.9% | 935 124.3% | 417 -12.5% | 476 105.9% | 231 73.3% | 133 13.1% | 118 19.1% | 99 8.3% | 91 14.2% | 80 - |
Net Worth (INR Cr) | 1429 34.3% | 1064 39.3% | 764 135.4% | 325 410.0% | -105 -242.0% | 74 0.0% | 40 2.2% | 39 52.4% | 26 37.9% | 19 31.0% | 14 0.0% |
Employee Cost (INR Cr) | 1652 12.8% | 1465 44.4% | 1014 89.4% | 536 44.8% | 370 0.7% | 367 - | 0 - | 0 - | 0 - | 0 - | 0 - |
Interest Cost (INR Cr) | 49 | 31 | 6 | 7 | 9 | 6 | 1 | 1 | 0 | 0 | 0 |
Cash & Bank Balance (INR Cr) | 191 | 86 | 517 | 140 | 180 | 37 | 4 | 3 | 6 | 4 | 5 |
Total Debt (INR Cr) | 490 | 503 | 66 | 51 | 168 | 69 | 12 | 5 | 0 | 0 | 2 |
PARAMETERS | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2014 | 2013 | 2012 | 2011 | 2010 |
---|---|---|---|---|---|---|---|---|---|---|---|
Profit As % Of Revenues | 12.2% | 11.3% | 9.8% | 14.5% | - | 2.5% | 8.2% | 7.7% | 9.9% | 10.7% | 11.5% |
Profit As % Of Assets | 16.6% | 15.3% | 17.6% | 35.8% | - | 6.1% | 5.8% | 5.6% | 6.2% | 4.8% | 4.7% |
Profit As % Of Networth | 23.6% | 25.0% | 21.6% | 46.0% | - | 19.1% | 19.2% | 16.9% | 23.8% | 23.7% | 26.4% |
Interest Cost to EBITDA % | 11.9% | 7.9% | 2.5% | 4.3% | 23.3% | 14.9% | 7.0% | 7.3% | 5.6% | 5.1% | 2.3% |
Debt to Equity Ratio | 0.34 | 0.47 | 0.09 | 0.16 | - | 0.93 | 0.31 | 0.12 | - | - | 0.11 |
RONW | 27.0% | 29.1% | 34.9% | 133.9% | - | 19.1% | 19.4% | 20.4% | 27.6% | 26.6% | 25.8% |
ROCE | 27.0% | 29.5% | 41.6% | 59.2% | 0.0% | 13.8% | 8.7% | 9.9% | 7.6% | 6.7% | 5.4% |